- Report
- December 2021
- 120 Pages
Global
From €3986EUR$4,500USD£3,454GBP
- Report
- November 2021
- 106 Pages
Global
From €3986EUR$4,500USD£3,454GBP
- Report
- October 2021
- 111 Pages
Global
From €3986EUR$4,500USD£3,454GBP
- Report
- October 2021
- 109 Pages
Global
From €3986EUR$4,500USD£3,454GBP
- Report
- October 2021
- 101 Pages
Global
From €3986EUR$4,500USD£3,454GBP
- Report
- May 2025
- 103 Pages
United Kingdom
From €3188EUR$3,599USD£2,762GBP
- Report
- June 2024
- 120 Pages
North America
From €3427EUR$3,869USD£2,970GBP
- Report
- May 2024
- 160 Pages
Global
From €4384EUR$4,949USD£3,799GBP
- Report
- May 2024
- 160 Pages
Global
From €4384EUR$4,949USD£3,799GBP
- Report
- May 2024
- 160 Pages
Global
From €4402EUR$4,969USD£3,814GBP
- Report
- May 2024
- 160 Pages
Global
From €4402EUR$4,969USD£3,814GBP
- Report
- May 2024
- 160 Pages
Global
From €4402EUR$4,969USD£3,814GBP
- Report
- May 2024
- 160 Pages
Global
From €4402EUR$4,969USD£3,814GBP
- Report
- May 2024
- 140 Pages
Global
From €4384EUR$4,949USD£3,799GBP
From €2471EUR$2,789USD£2,141GBP
- Report
- February 2024
- 180 Pages
Global
From €4402EUR$4,969USD£3,814GBP
- Report
- February 2024
- 180 Pages
Global
From €4402EUR$4,969USD£3,814GBP
- Report
- February 2024
- 180 Pages
Global
From €4402EUR$4,969USD£3,814GBP
- Report
- February 2024
- 160 Pages
Africa
From €3427EUR$3,869USD£2,970GBP
- Report
- February 2024
- 180 Pages
Global
From €4402EUR$4,969USD£3,814GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more